These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cancer Cell Plasticity: Rapid Reversal of Chemosensitivity and Expression of Stemness Markers in Lung and Breast Cancer Tumorspheres. Yakisich JS; Azad N; Kaushik V; Iyer AKV J Cell Physiol; 2017 Sep; 232(9):2280-2286. PubMed ID: 27925198 [TBL] [Abstract][Full Text] [Related]
23. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells. Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574 [TBL] [Abstract][Full Text] [Related]
24. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer. Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309 [TBL] [Abstract][Full Text] [Related]
25. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling. Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949 [TBL] [Abstract][Full Text] [Related]
26. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells. Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848 [TBL] [Abstract][Full Text] [Related]
27. Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway. Sánchez-Botet A; Quandt E; Masip N; Escribá R; Novellasdemunt L; Gasa L; Li VSW; Raya Á; Clotet J; Ribeiro MPC Cell Oncol (Dordr); 2021 Dec; 44(6):1273-1286. PubMed ID: 34604945 [TBL] [Abstract][Full Text] [Related]
28. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation. Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842 [TBL] [Abstract][Full Text] [Related]
30. Cancer stem cells in breast cancer. Dittmer J; Rody A Histol Histopathol; 2013 Jul; 28(7):827-38. PubMed ID: 23468411 [TBL] [Abstract][Full Text] [Related]
31. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Al-Dhfyan A; Alhoshani A; Korashy HM Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884 [TBL] [Abstract][Full Text] [Related]
32. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway. Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365 [TBL] [Abstract][Full Text] [Related]
33. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium. Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441 [TBL] [Abstract][Full Text] [Related]
34. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma. Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365 [TBL] [Abstract][Full Text] [Related]
35. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310 [TBL] [Abstract][Full Text] [Related]
36. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma. Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699 [TBL] [Abstract][Full Text] [Related]
37. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma. Lu H; Ju DD; Yang GD; Zhu LY; Yang XM; Li J; Song WW; Wang JH; Zhang CC; Zhang ZG; Zhang R EBioMedicine; 2019 Feb; 40():276-289. PubMed ID: 30594556 [TBL] [Abstract][Full Text] [Related]
38. Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling. Eyre R; Alférez DG; Santiago-Gómez A; Spence K; McConnell JC; Hart C; Simões BM; Lefley D; Tulotta C; Storer J; Gurney A; Clarke N; Brown M; Howell SJ; Sims AH; Farnie G; Ottewell PD; Clarke RB Nat Commun; 2019 Nov; 10(1):5016. PubMed ID: 31676788 [TBL] [Abstract][Full Text] [Related]
39. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer. Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783 [TBL] [Abstract][Full Text] [Related]
40. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway. Zhang X; Zhang R; Hou C; He R; Wang QS; Zhou TH; Li XQ; Zhai QL; Feng YM J Biol Chem; 2022 Jul; 298(7):102082. PubMed ID: 35660418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]